These products were stopped in time before they could reach the public and potentially cause harm
Novo Nordisks list price reduction to $675/month takes effect in January 2027, and Medicares negotiated price of $274/month will further improve affordability for eligible beneficiaries
In the SUSTAIN clinical trial program evaluating subcutaneous semaglutide for type 2 diabetes, once-weekly dosing (0.5 mg or 1.0 mg) reduced HbA1c by 1.5% to 1.8% from baseline, with superior glycemic control compared to specific comparators in head-to-head trials (SUSTAIN-7 vs dulaglutide
These drugs can cross the BBB, reduce insulin resistance, stabilize mitochondrial function, and increase the survival and functional state of neurons
Everything I learned from the treatmentand what I wish I knew beforeahead
Ignoring early warning signs of irritation and pushing through leads to more severe problems